Search Count: 10
 |
Crystal Structure Of Leukotoxin Luke From Staphylococcus Aureus At 1.9 Angstrom Resolution
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-04-06 Classification: TOXIN Ligands: P6G, MHA, SO4 |
 |
Crystal Structure Of Leukotoxin Luke From Staphylococcus Aureus At 1.5 Angstrom Resolution
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2022-04-06 Classification: TOXIN Ligands: CL |
 |
Crystal Structure Of Leukotoxin Luke From Staphylococcus Aureus In Complex With P-Cresyl Sulfate
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-04-06 Classification: TOXIN Ligands: PEG, IMD, SO4, 6EI |
 |
Crystal Structure Of Leukotoxin Luke From Staphylococcus Aureus In Complex With A Doubly Sulfated Ccr2 N-Terminal Peptide
Organism: Staphylococcus aureus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2022-04-06 Classification: TOXIN Ligands: IMD, SO4 |
 |
Crystal Structure Of Leukotoxin Luke From Staphylococcus Aureus In Complex With A Sulfated Ackr1 N-Terminal Peptide
Organism: Staphylococcus aureus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2022-04-06 Classification: TOXIN |
 |
First Domain Of Human Bromodomain Brd4 In Complex With Inhibitor N-{3-[4-(3-Chlorophenyl)Piperazin-1-Yl]Propyl}-1-{3-Methyl-[1,2,4]Triazolo[4,3-B]Pyridazin-6-Yl}Piperidine-4-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2016-06-01 Classification: TRANSCRIPTION Ligands: 5D2 |
 |
First Domain Of Human Bromodomain Brd4 In Complex With Inhibitor 4-[(1-Methyl-2-Oxo-1,2-Dihydroquinolin-4-Yl)Oxy]-N-({1-[(3-Methylphe Methyl]Piperidin-4-Yl}Methyl)Butanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2016-06-01 Classification: TRANSCRIPTION Ligands: 5D1 |
 |
First Domain Of Human Bromodomain Brd4 In Complex With Inhibitor 3-Butyl-8-(6-Butyl-5,7-Dimethyl-[1,2,4]Triazolo[1,5-A]Pyrimidin-2-Ylsulfanylmethyl)-7-Ethyl-3,7-Dihydropurine-2,6-Dione
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2016-01-20 Classification: TRANSCRIPTION Ligands: 5NQ, EDO |
 |
First Domain Of Human Bromodomain Brd4 In Complex With Inhibitor 8-(5-Amino-1H-[1,2,4]Triazol-3-Ylsulfanylmethyl)-3-(4-Chlorobenzyl)-7-Ethyl-3,7-Dihydropurine-2,6-Dione
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.05 Å Release Date: 2016-01-20 Classification: TRANSCRIPTION Ligands: EDO, 5NV |
 |
First Domain Of Human Bromodomain Brd4 In Complex With Inhibitor 3-(4-Chlorobenzyl)-7-Ethyl-3,7-Dihydropurine-2,6-Dione
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2016-01-20 Classification: TRANSCRIPTION Ligands: 5OU, EDO |